VEGFA and neoplasm: SPR965 specially reduced the expression of phosphorylation of AKT and S6 and significantly inhibited tumor growth in our KpB mice accompanied by decreased levels of Ki-67, VEGF, phosphylated-AKT and phosphylated-S6 protein expression, as well as increased the expression of Bip in tumor tissues.